Predicting bowel disease in premature babies using gut bacteria
Part of Digestive system clinical trials.
This study looks at the gut bacteria of premature babies to see if changes can predict a serious bowel condition (ulcero-necrotizing enterocolitis). It aims to use artificial intelligence to help doctors catch it early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 34 weeks of pregnancy.
- Your baby is in a neonatal intensive care unit at a university hospital in the Auvergne-Rhône-Alpes region of France.
- If your baby was born elsewhere, they must have been moved to the study hospital within 24 hours of birth.
- You have legal authority to make decisions for your baby and are at least 18 years old.
- You agree to let your baby take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving premature babies a daily probiotic (a mix of healthy bacteria) can help prevent a serious gut condition called necrotizing enterocolitis. If it works, it could keep your baby safer and healthier.
This study looks at how immune-related “NETs” might protect or possibly harm newborn babies during early inflammation or infection. It may help doctors understand which immune responses are helpful versus risky in the NICU.
This study looks at whether a simple stool test and a heart monitor can help doctors predict a serious bowel condition in premature babies who are having trouble feeding. It aims to find early signs so treatment can start sooner.
This study tests a monitoring tool to help doctors spot a serious gut problem in premature babies born before 32 weeks. If the tool works, it could lead to earlier treatment and better outcomes.
This study looks at whether giving probiotics (good bacteria) to very premature babies (born before 32 weeks) can lower the risk of a serious gut problem called necrotizing enterocolitis (NEC). The researchers will review medical records of babies born between 2016 and 2022 in England and Wales.
This study looks at a stool test (fecal calprotectin) to see if it differs between preterm babies fed breast milk versus formula, and if it can help spot a serious gut condition called necrotizing enterocolitis (NEC). It may help find early signs of this condition.
Hear when a new Necrotizing Enterocolitis (NEC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.